Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/14/22
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 02/18/21
End: 01/07/22
Due: 01/07/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Demonstration of a Digital Care Program for Methamphetamine Use Disorder | NCT05206175 | Affect Therapeutics, Inc. | user2@example.com | None | 2022-02-14 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Field Study of a Digital Therapeutic Platform to Facilitate Treatment for Methamphetamine-Primary Stimulant Use Disorder | NCT05266716 | Affect Therapeutics, Inc. | user2@example.com | None | 2021-02-18 | 2022-01-07 | 2023-01-07 | - | - | 2025-07-14 |